Wisdom Bioscience Forms Scientific Advisory Board to Advance Oral Cancer Diagnostics

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening Wisdom Bioscience, a biotechnology company revolutionizing oral cancer diagnostics, has announced the formation of its Scientific Advisory Board (SAB) following a successful initial funding round. The SAB…

Read MoreWisdom Bioscience Forms Scientific Advisory Board to Advance Oral Cancer Diagnostics

Roche’s Fenebrutinib Confirms Potential as First BTK Inhibitor for MS in Third Positive Phase III Trial (FENhance 1)

Roche’s fenebrutinib reaffirms potential as the sole BTK inhibitor for relapsing and primary progressive MS with positive FENhance 1 Phase III results. Roche announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary…

Read MoreRoche’s Fenebrutinib Confirms Potential as First BTK Inhibitor for MS in Third Positive Phase III Trial (FENhance 1)